Eat Well Investment Group Inc. Closes $5.1 Million Oversubscribed Marketed Private Placement - Seite 2

In the event that the Company has not received a receipt for the Final Prospectus within 90 days following the Closing, each unexercised Special Warrant will thereafter entitle the holder thereof to receive upon the exercise thereof, at no additional consideration, one-and-one-tenth (1.10) Unit (instead of one Unit); and thereafter, at the end of any additional thirty (30) day period prior to the Qualification Date (as defined below), each Special Warrant will be exercisable for an additional 0.02 of a Unit.

All unexercised Special Warrants will automatically be exercised on the date (the “Qualification Date”) that is the earlier of (i) four (4) months and a day following Closing of the Offering, and (ii) as soon as reasonably practicable, and no later than the 3rd business day after, a receipt is issued for the Final Prospectus.

The Agents received an aggregate cash fee equal to 7.0% of the gross proceeds from the Offering (subject to a reduced 3.5% cash fee in respect of subscribers on a president’s list (the “President’s List”)). In addition, the Company granted the Agents non-transferable compensation warrants (the “Compensation Warrants”) equal to 7.0% of the total number of Special Warrants under the Offering (subject to a reduced rate of 3.5% in respect of subscribers on the President’s List). Each Compensation Warrant entitles the holder thereof to purchase one Unit (a “Compensation Warrant Unit”) at an exercise price per Compensation Warrant Unit equal to the issue price of the Special Warrants for a period of 36 months following the closing of the Offering.

The Offering remains subject to final acceptance by the Canadian Securities Exchange (the "CSE").

For further details of the Offering, see the Company’s November 25, 2021 news release, which is available on the Company’s profile at www.sedar.com.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States or any other jurisdiction in which such offer, solicitation or sale would be unlawful. Such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and, accordingly, may not be offered or sold in the United States or to, or for the account or benefit of, “U.S. persons” (as those terms are defined in Regulation S under the U.S. Securities Act) absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.